公司資料
Sanofi 股價、新聞與催化劑
- 股票代碼:
- SNY
- 交易所:
- NASDAQ
- 產業:
- Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
- 所在地:
- France and listed in the U
股票表現
44.41 USD (+1.58%)
收盤價
最後更新: 2026年8月17日
102B USD
市值
股價為何變動
As of Aug 17, 2026, SNY closed up 1.58% at $44.41. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Sanofi is a global healthcare company with meaningful exposure to immunology, vaccines, rare disease, and consumer health. The company has been building a more focused innovation story while maintaining a broad global base.
所在地與產業分類
Headquartered in France and listed in the U.S. as an ADR, Sanofi operates globally across Europe, the U.S., and other major markets. It is one of the largest international biopharma names.
商業模式特徵
Sanofi combines product revenue with pipeline investment and portfolio restructuring. Investors focus on immunology growth, vaccine performance, and the company’s ability to keep improving its innovation mix.
生技產業定位
Sanofi sits in the upper tier of global biopharma, where scale and pipeline quality matter more than single-stock binary events. It still reacts to major clinical and regulatory updates, especially in immunology and rare disease.
未來催化劑
- Sanofi should be watched for amlitelimab, tolebrutinib, and the broader immunology pipeline, where any positive progression would reinforce the company’s growth profile. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。